No CrossRef data available.
Article contents
Percutaneous tricuspid valve implantation: an alternative in critically ill patients
Part of:
Interventional Cardiology
Published online by Cambridge University Press: 04 February 2022
Abstract
Tricuspid valvulopathy has gained a lot of attention in recent years, especially due to the advances in percutaneous management. CHD can present with primary or secondary malfunction of the tricuspid valve, often not addressed due to high surgical risk after several interventions. We present two cases of adults with complex congenital heart malformations and borderline clinical situations who successfully underwent percutaneous tricuspid replacement.
- Type
- Brief Report
- Information
- Copyright
- © The Author(s), 2022. Published by Cambridge University Press
References
Sanon, S, Cabalka, AK, Babaliaros, V, et al. Transcatheter tricuspid valve-in-valve and valve-in-ring implantation for degenerated surgical prosthesis. JACC Cardiovasc Interv 2019; 12: 1403–1412.CrossRefGoogle ScholarPubMed
Coserria-Sánchez, F, Iglesias-López, Á, Zunzunegui-Martínez, JL, et al. Percutaneous pulmonary melody valve implantation through the transhepatic route in an 8-year-old patient. Rev Esp Cardiol (Engl Ed) 2018; 71: 861–862.CrossRefGoogle Scholar
Aboulhosn, J, Cabalka, AK, Levi, DS, et al. Transcatheter valve-in-ring implantation for the treatment of residual or recurrent tricuspid valve dysfunction after prior surgical repair. JACC Cardiovasc Interv 2017; 10: 53–63.CrossRefGoogle ScholarPubMed